Noticeable phenomena of aggravated profitability with listed pharmaceutical companies

Published: 2014-12-02 13:31:17

Updated: 2014-12-02 13:31:31

It is expected that profitability of listed pharmaceutical companies will keep being aggravated.

Sales of the third quarter have recorded the average as the last year, but business profits and net profits do not seem to improve.

The YakupDotCom’s (www.yakup.com) analysis of the 2014 third quarter reports that listed pharmaceutical companies turned in to the Financial Supervisory Servicein 30 ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.